country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-15779

Copy Link Print Information

K145

Name: K145
Brand: MedChemExpress
SKU: HY-15779
Availability: PreOrder

6 Cited Publications

カスタマーレビュー

Based on 6 publication(s) in Google Scholar

K145 is a selective, substrate-competitive and orally active SphK2 inhibitor with an IC₅₀ of 4.3 µM and a K_i of 6.4 µM. K145 is inactive against SphK1 and other protein kinases. K145 induces cell apoptosis and has potently antitumor activity.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 1309444-75-4
分子式: C₁₈H₂₄N₂O₃S
分子量:348.46

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (270 KB)

K145 構造式

CAS 番号: 1309444-75-4

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- IC₅₀ & Target
- 体外実験
- 体内実験
化学情報
Publications (6)
純度とドキュメンテーション
参考文献
Calculators
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target

IC50: 4.3 µM (SphK2)^[1]
Ki: 6.4 µM (SphK2)^[1]

SphK アイソフォーム固有の製品をすべて表示 :

SphK1
SphK2

体外実験

K145 (0-10 µM; 24-72 hours; U937 cells) treatment significantly inhibits the growth of U937 cells in a concentration-dependent manner^[1].
K145 (10 µM; 24 hours; U937 cells) treatment significantly induces apoptosis in U937 cells^[1].
K145 (4-8 µM; 3 hours; U937 cells) treatment decreases the phosphorylation of ERK and Akt^[1].
Treatment with K145 (10 µM) causes a decrease of total cellular S1P without significant effects on ceramide levels^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

U937 cells
Concentration:

0 µM, 4 µM, 6 µM, 8 µM, 10 µM
Incubation Time:

24 hours, 48 hours, 72 hours
Result:

Significantly inhibited the growth of U937 cells in a concentration-dependent manner.

Apoptosis Analysis^[1]

Cell Line:

U937 cells
Concentration:

10 µM
Incubation Time:

24 hours
Result:

Significantly induced apoptosis in U937 cells.

Western Blot Analysis^[1]

Cell Line:

U937 cells
Concentration:

4 µM, 8 µM
Incubation Time:

3 hours
Result:

Phosphorylated ERK and Akt were decreased.

体内実験

K145 (50 mg/kg; oral gavage; daily; for 15 days; BALB/c-nu mice) treatment significantly inhibits the growth of U937 tumors in nude mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

BALB/c-nu mice injected with U937 cells^[1]
Dosage:

50 mg/kg
Administration:

Oral gavage; daily; for 15 days
Result:

Oral gavage; daily; for 15 daysInhibited the growth of U937 tumors at 50 mg/kg dose and no apparent toxicity was observed.

化学情報

CAS 番号 1309444-75-4
分子量 348.46
分子式 C₁₈H₂₄N₂O₃S
SMILES

O=C(N(CCN)C/1=O)SC1=C/CCC2=CC=C(OCCCC)C=C2
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

Publications (6)

All WB

Sort by:

Journal Impact Factor

Sci China Life Sci

NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry. [Abstract]

2022 Feb;65(2):341-361. PMID: 34047913
Channels

Sphingosine kinase 2 inhibitor ABC294640 suppresses neuronal excitability and inhibits multiple endogenously and exogenously expressed voltage-gated ion channels in cultured cells. [Abstract]

2020 Dec;14(1):216-230. PMID: 32615066
Exp Mol Pathol

Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation-induced cell apoptosis via sphingosine kinase 2 and FAK/AKT pathway. [Abstract]

2016 Feb;100(1):51-8. PMID: 26621495
Am J Cancer Res

Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma. [Abstract]

2019 Mar 1;9(3):546-561. PMID: 30949409

K145 purchased from MedChemExpress. Usage Cited in: Am J Cancer Res. 2019 Mar 1;9(3):546-561. [Abstract]

Western immunoblotting analysis of NOXA protein levels in RBE and HCCC9810 cells treated with different concentrations of K145 for 24 h. Data shown represents 2 independent experiments.
Biochem Biophys Res Commun

The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver. [Abstract]

2021 Sep 28;580:1-6. PMID: 34607257
Biochem Biophys Res Commun

3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) ameliorated dexamethasone induced hepatic gluconeogenesis through activation of Akt/FoxO1 pathway. [Abstract]

2017 Nov 4;493(1):286-290. PMID: 28911865

K145 purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2017 Nov 4;493(1):286-290. [Abstract]

Inhibition of pAkt by API-2 effectively prevents K145 induced increasing phosphorylation of FoxO1 in response to insulin. API-2 also significantly reverses K145 suppressed PEPCK and G6Pase mRNA and protein expression.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (270 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Liu K, et al. Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent. PLoS One. 2013;8(2):e56471. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

K145

6 Cited Publications

100 mg お問い合わせ

Subscribe to the

MedChemExpress

Newsletter

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ

Amount: USD 0.00

生物活性
- 製品説明
- IC₅₀ & Target
- 体外実験
- 体内実験
化学情報
Publications (6)
純度とドキュメンテーション
参考文献

1/16
1/16

K145 purchased from MedChemExpress. Usage Cited in: Am J Cancer Res. 2019 Mar 1;9(3):546-561. [Abstract]

Customer Validation
Western immunoblotting analysis of NOXA protein levels in RBE and HCCC9810 cells treated with different concentrations of K145 for 24 h. Data shown represents 2 independent experiments.
1/16

K145 purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2017 Nov 4;493(1):286-290. [Abstract]

Customer Validation
Inhibition of pAkt by API-2 effectively prevents K145 induced increasing phosphorylation of FoxO1 in response to insulin. API-2 also significantly reverses K145 suppressed PEPCK and G6Pase mRNA and protein expression.

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

K145

MP-A08

PF-543 Citrate

MHP

K145 hydrochloride

SKI-178

PF-543

SKI II

SK1-IN-1

Phorbol 12-myristate 13-acetate

MHP (Standard)

SK1-I

SKI V

MedChemExpress（MCE）の使用を引用している文献 K145

SphK アイソフォーム固有の製品をすべて表示

生物活性

化学情報

Publications (6)

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

Bioz

K145

MP-A08

PF-543 Citrate

MHP

K145 hydrochloride

SKI-178

PF-543

SKI II

SK1-IN-1

Phorbol 12-myristate 13-acetate

MHP (Standard)

SK1-I

SKI V

MedChemExpress（MCE）の使用を引用している文献 K145

SphK アイソフォーム固有の製品をすべて表示

生物活性

化学情報

Publications (6)

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

K145 関連分類

HY-15779 関連分類

Bioz